UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019423
Receipt number R000021082
Scientific Title the effectiveness of the nasal airway stent (nastentTM) in sleep apnea syndrome
Date of disclosure of the study information 2015/10/20
Last modified on 2017/06/26 16:13:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

the effectiveness of the nasal airway stent (nastentTM) in sleep apnea syndrome

Acronym

NASstudy

Scientific Title

the effectiveness of the nasal airway stent (nastentTM) in sleep apnea syndrome

Scientific Title:Acronym

NASstudy

Region

Japan


Condition

Condition

sleep apnea syndrome

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

the invistigation of the effectiveness of nasal airway device(nastentTM) in sleep apnea syndrome

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

change of AHI after the indication of nasal airway stent(nastentTM) treatment in one month and three months

Key secondary outcomes

frequency of adverse effect after the indication of nasal airway stent(nastentTM)in one month and three months


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

To evaluate the changes of self synptoms used of a questionnaire survey and AHI used of portable instrument before and after the use of nasal airway devices in one month and three months against sleep apnea syndrome patients

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

sleep apnea syndrome patients(AHI under20 in PSG)who will recieve a treatment of nasal airway device(nastentTM)

Key exclusion criteria

the patients who cannot continue the use of the nasal airway stent(nastentTM) or attend a hospital

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Fukunaga Koichi

Organization

Keio University school of medicine

Division name

pulmonary devision

Zip code


Address

shinanomachi35,shinjyukuku,tokyo

TEL

03-3353-1211

Email

k-fuku@jf7.so-net.ne.jp


Public contact

Name of contact person

1st name
Middle name
Last name Fukunaga koichi

Organization

Keio University school of medicine

Division name

pulmonary devision

Zip code


Address

shinanomachi35,shinjyukuku,tokyo

TEL

03-3353-1211

Homepage URL


Email

k-fuku@jf7.so-net.ne.jp


Sponsor or person

Institute

Keio University school of medicine pulmonary division

Institute

Department

Personal name



Funding Source

Organization

seven dreamers laboratories, inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

慶應義塾大学病院(東京都)、RESM新横浜睡眠呼吸メディカルクリニック(神奈川県)
新宿睡眠メディカルクリニック(東京都)


Other administrative information

Date of disclosure of the study information

2015 Year 10 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 07 Month 07 Day

Date of IRB


Anticipated trial start date

2015 Year 07 Month 21 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 10 Month 20 Day

Last modified on

2017 Year 06 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021082


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name